Speaking on: CRISPR-Cas9 screen identifies Eif4g2 as a novel regulator of CD8+ T cell dysfunction.
Wednesday, April 17, 2024
CanBio Bagel Talk
9:00 AM to 10:00 AM
Hybrid meeting:
In-person at the Rogel Cancer Center, room 3206
or virtual Zoom meeting
Erin Holcomb in the Green lab